The Social Security budget for 2023 “requires efforts from pharmaceutical laboratories”, Prime Minister Elisabeth Borne said on Monday, highlighting their “significant turnover due to the health crisis”.
The Social Security financing bill, presented this morning in the Council of Ministers, requires efforts from pharmaceutical companies, she declared on BFMTV and RMC.
The Prime Minister did not specify the amount or the terms of this contribution, but they will help out, she insisted.
We can all see that they have achieved a significant turnover due to the health crisis and therefore today, I think it is important that they participate in the effort, she explained.
The draft law, consulted by AFP, includes a chapter on the regulation of health product expenditure.
The text provides for a sharp drop in the deficit of the Scu, from 17.8 billion euros in 2022 to 6.8 billion in 2023.
Invest in the Scholarship at the best price ! 7 offers compared
This improvement would mainly benefit the health branch, whose losses would be reduced from around 20 billion this year to 6.5 billion next year.
A drop partly enabled by regulatory measures and savings, amounting to a total of 1.7 billion euros, according to this document.